Procedure and Outcome of Prequalification of Medicines Program by World Health Organization (WHO)

Rumel Dey, Rafiqul Islam, Maria Ferdous and Dona Roy Chowdury
Additional contact information
Maria Ferdous: Department of Global Regulatory Affairs, Square Pharmaceuticals Ltd., Bangladesh
Dona Roy Chowdury: Department of Product Management, Eskayef Pharmaceuticals Ltd., Dhaka, Bangladesh

Biomedical Journal of Scientific & Technical Research, 2020, vol. 28, issue 1, 21330-21338

Abstract: In March 2001, World Health Organization (WHO) Prequalification of Medicines Program (PQP) comes in action...

Keywords: World Health Organization (WHO); Prequalification of Medicines Program (PQP); United Nations (UN); Active Pharmaceutical Ingredients (API); Finished Pharmaceuticals Products (FPPs); Quality Control Laboratories (QCLs); Expression of Interest (EOI); Site Master File (SMF); Contact Research Organizations (CROs); WHO Public Assessment Reports (WHOPARs); WHO Public Inspection Reports (WHOPIRs); Essential Medicines List (EML) (search for similar items in EconPapers)
Date: 2020
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.004607.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.004607.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:28:y:2020:i:1:p:21330-21338

DOI: 10.26717/BJSTR.2020.28.004607

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().